Chelsea proceed Jan. spree, signal PSV's Madueke


Chelsea have accomplished the signing of winger Noni Madueke from PSV Eindhoven, the Premier League membership introduced Friday.

Madueke, 20, signed a seven-and-a-half-year contract, with a membership choice to increase for an additional 12 months. Experiences counsel the entire switch payment is round €35 million ($38m).

Stream on ESPN+: LaLiga, Bundesliga, extra (U.S.)

Chelsea agreed a cope with PSV on Thursday, with the England Underneath-21 worldwide receiving permission to journey to London to finish the switch.

“I’m really pleased to sign with one of the best clubs in the world in Chelsea,” Madueke stated.

“To return to England and play in the Premier League is a dream for me and my family and I can’t wait to get started. I am excited for what the future holds, the owner’s vision for the future and to be at a club like this and winning at the highest level.”

Added Chelsea chairman Todd Boehly and co-controlling proprietor Behdad Eghbali: “We’re delighted to bring Noni to Chelsea. He’s an exciting talent who has proven his quality over the past few years with PSV, playing in a strong European league, and we are thrilled he has chosen to join Chelsea for this next stage of his career.

“We’re positive he’ll kind an vital a part of our group.”

Madueke joined PSV’s youth team on 2018 and made his debut with the senior team two years later. Since then, he scored 20 goals and provided 14 assists in 80 appearances.

Formerly a youth team player at Tottenham and Chelsea, Madueke is said to have been tracked by Chelsea head coach Graham Potter for some time.

He now becomes Chelsea’s sixth signing of the January transfer window and is the latest boost to Potter’s attacking options.

The Blues had already signed winger Mykhailo Mudryk from Shakhtar Donetsk in a deal worth up to €100m, as well as adding Joao Felix on loan from Atletico Madrid.

Data from Reuters was used on this story.

Supply hyperlink –

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More